These data indicate that KCs, in contrast to BMDMs, represent a potent barrier to the liver engraftment of tumour cells circulating in the portal vein, and exert a strong and long-lasting inhibitory effect on their subsequent growth in the liver and the lungs. This evidence concerns the gene TBCE and neoplasm.